Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout Find out more athttps://LifeScienceTodayPodcast.com Story References Sanofi/Takeda UniQure & CSLFog PharmaMerck + Imago About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical ..read more

A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals Find out more athttps://LifeScienceTodayPodcast.com Story References Indivior + OpiantRegeneron + CytomXRezo Prevention About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, includ ..read more

More CRISPR data, oncology wins, and a new player in ophthalmology Find out more athttps://LifeScienceTodayPodcast.com Story References Intellia Regeneron Viatris + Oyster Point About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that d ..read more

Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others Find out more athttps://LifeScienceTodayPodcast.com Story References Sumitovant + MyovantThermo Fisher + Binding Site GroupAstellas & TayshaAgios Vaxctye About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also ..read more

Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more athttps://LifeScienceTodayPodcast.com Story References FDA AbbVie + DJSRoche + HookipaKyverna About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, inc ..read more

One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more athttps://LifeScienceTodayPodcast.com Story References DICE Odyssey Fred HutchMerck (MSD), Merck Story 2 About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around cl ..read more

Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC Find out more athttps://LifeScienceTodayPodcast.com Story References Nested TherapeuticsCellarity ReplimuneEstrella Biopharma About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around ..read more

Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC Find out more athttps://LifeScienceTodayPodcast.com Story References Nested TherapeuticsCellarity ReplimuneEstralla Biopharma About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around ..read more

Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions Find out more athttps://LifeScienceTodayPodcast.com Story ReferencesEisai + BiogenAmylyx Sanofi + Regeneron About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving p ..read more

A $900 raise, gene therapy news, a quick IPO, and merge three for $100M Find out more athttps://LifeScienceTodayPodcast.com Story ReferencesAlnylam, Link 2, Link 3 Intellia Therapeutics Third Harmonic BioGalvanize Therapeutics About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical ..read more